Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004628 |
---|---|
Receipt number | R000005522 |
Scientific Title | Examination of efficacy and safety of administration of vitamin D3 with the PEG-IFN alpha 2a/Ribavirin therapy to hepatitis C patients with osteoporosis. |
Date of disclosure of the study information | 2010/12/01 |
Last modified on | 2017/11/13 09:50:18 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/11/27 00:06:15 | ||
2 | Update | 2011/11/28 07:44:59 | Public title Public title Acronym Acronym |
|
3 | Update | 2011/11/28 07:46:13 | Condition Condition Narrative objectives1 Narrative objectives1 |
|
4 | Update | 2011/11/28 07:52:49 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key inclusion criteria |
|
5 | Update | 2011/11/28 07:53:27 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
6 | Update | 2011/11/28 07:55:24 | Date of protocol fixation Anticipated trial start date |
|
7 | Update | 2012/05/28 07:37:18 | Recruitment status |
|
8 | Update | 2013/05/02 08:32:33 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
9 | Update | 2013/05/02 08:37:04 | Email |
|
10 | Update | 2017/11/13 09:50:18 | UMIN ID1 |